Progyny, Inc. (PGNY) Stock Analysis

Navigation

Explore Analysis Investor Relations AI Assistant Compare Screener

Help Pricing Privacy Terms

Navigation

Explore Analysis Investor Relations AI Assistant Compare Screener

Help Pricing Privacy Terms

Progyny, Inc. (PGNY) Stock Analysis — AI Research | MarketCI

PGNY

Market Closed

Progyny, Inc.

NASDAQHealthcare Medical - Healthcare Information Services

675 employees

CEO: David J. Schlanger

Founded: 2019

$26.60

+$0.00(+NaN%)

Market Cap

2.08B

Beta

1.04

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

PGNY Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for PGNY built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Hold

Pass %

57.14%

Score

4/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$22.54

AI Price Target

Machine learning • Price prediction

$26.31

Market Sentiment

News & social media analysis

0.00

Value Investor Price

Classic value analysis

$6.05

Financial Health

Bankruptcy risk assessment

7.92

Quality Score

Financial strength rating

6.00

AI Investment Grade

Deep analysis of filings & news

75.00

Key Investment Highlights

Important factors affecting PGNY investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Loading analysis...

Due Diligence Conditions

Investment analysis conditions and results